Oscar Health, Inc. (NYSE:OSCR) Receives $24.17 Average Price Target from Analysts

Oscar Health, Inc. (NYSE:OSCR) has been given a consensus recommendation of “Moderate Buy” by the eight analysts that are covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $24.00.

OSCR has been the subject of several research analyst reports. Piper Sandler restated an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. UBS Group started coverage on Oscar Health in a report on Monday. They set a “neutral” rating and a $23.00 target price for the company. Finally, Wells Fargo & Company lifted their price target on Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 12th.

Insider Buying and Selling

In other Oscar Health news, CAO Victoria Baltrus sold 4,226 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $76,025.74. Following the completion of the sale, the chief accounting officer now directly owns 140,648 shares of the company’s stock, valued at $2,530,257.52. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CAO Victoria Baltrus sold 4,226 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $76,025.74. Following the completion of the sale, the chief accounting officer now owns 140,648 shares of the company’s stock, valued at approximately $2,530,257.52. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the transaction, the insider now directly owns 76,982 shares in the company, valued at $1,384,906.18. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 169,569 shares of company stock worth $3,007,069. 25.11% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in OSCR. Avalon Trust Co purchased a new stake in Oscar Health in the first quarter valued at $69,000. Point72 Hong Kong Ltd acquired a new stake in shares of Oscar Health during the 2nd quarter worth about $78,000. Quest Partners LLC purchased a new stake in Oscar Health in the 2nd quarter valued at about $93,000. Amalgamated Bank lifted its position in Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock valued at $106,000 after buying an additional 1,458 shares during the last quarter. Finally, Farallon Capital Management LLC purchased a new position in Oscar Health during the first quarter worth about $164,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Stock Down 1.1 %

Shares of OSCR opened at $18.28 on Friday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26. The firm has a market cap of $4.34 billion, a P/E ratio of -45.70, a PEG ratio of 40.11 and a beta of 1.62. The stock’s 50 day moving average is $18.98 and its two-hundred day moving average is $18.09. Oscar Health has a 12 month low of $4.72 and a 12 month high of $23.79.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.16 by $0.04. The company had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.13 billion. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The firm’s revenue was up 44.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.07) EPS. Analysts predict that Oscar Health will post 0.01 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.